PPARα-dependent increase of mouse urine output by gemfibrozil and fenofibrate

While gemfibrozil and fenofibrate are prescribed for anti-dyslipidemia treatment, a rational basis for the use of these drugs for treatment of dyslipidemia with concurrent metabolic syndrome has not been established. In this study, wild-type and Pparα-null mice were fed gemfibrozil- or fenofibrate-c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Can J Physiol Pharmacol
Asıl Yazarlar: Song, Danjun, Luo, Min, Dai, Manyun, Bu, Shizhong, Wang, Weihua, Zhang, Burong, Gonzalez, Frank J., Liu, Aiming
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6334299/
https://ncbi.nlm.nih.gov/pubmed/27918198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1139/cjpp-2016-0140
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller